Intranasal Administration of a Therapeutic HIV Vaccine (Vacc-4x) Induces Dose-Dependent Systemic and Mucosal Immune Responses in a Randomized Controlled Trial

Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial

(2014) Richard B Pollard et al.   LANCET INFECTIOUS DISEASES

A Parameter for IL-10 and TGF-ß Mediated Regulation of HIV-1 Specific T Cell Activation Provides Novel Information and Relates to Progression Markers

(2014) Andreas Lind et al.   PLoS One

Intranasally administered Endocine™ formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets

(2014) Anna-Karin Maltais et al.   VACCINE

CD8+T-cell effector function and transcriptional regulation during HIV pathogenesis

(2013) Korey R. Demers et al.   IMMUNOLOGICAL REVIEWS

Immune interventions in HIV infection

(2013) Guislaine Carcelain et al.   IMMUNOLOGICAL REVIEWS

The end of AIDS: HIV infection as a chronic disease

(2013) Steven G Deeks et al.   LANCET

Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

(2013) Christine Katlama et al.   LANCET

Mucosal immunity in human and simian immunodeficiency lentivirus infections

(2013) J M Brenchley   Mucosal Immunology

Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes

(2013) Geert Leroux-Roels et al.   PLoS One

Endocine™, N3OA and N3OASq; Three Mucosal Adjuvants That Enhance the Immune Response to Nasal Influenza Vaccination

(2013) Tina Falkeborn et al.   PLoS One

Boosters of a therapeutic HIV-1 vaccine induce divergent T cell responses related to regulatory mechanisms

(2013) Andreas Lind et al.   VACCINE

CD8+ T cells in preventing HIV infection and disease

(2012) Adrian B. McDermott et al.   AIDS

Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation

(2012) Liang Shan et al.   IMMUNITY

Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years

(2012) Andreas Lind et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Therapeutic vaccines against HIV infection

(2012) Felipe García et al.   Human Vaccines & Immunotherapeutics

HIV and Inflammation: Mechanisms and Consequences

(2012) Peter W. Hunt   Current HIV/AIDS Reports

Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges

(2011) Morgane Bomsel et al.   IMMUNITY

T cell exhaustion

(2011) E John Wherry   NATURE IMMUNOLOGY

New insights in mucosal vaccine development

(2011) Vincent Pavot et al.   VACCINE

Low frequency of amino acid alterations following therapeutic immunization with HIV-1 Gag p24-like peptides

(2010) Anne-Marte B Kran et al.   AIDS

Good cell, bad cell: Flow cytometry reveals T-cell subsets important in HIV disease

(2010) Pratip K. Chattopadhyay et al.   CYTOMETRY PART A

Regulatory T Cell Suppression of Gag-Specific CD8+ T Cell Polyfunctional Response After Therapeutic Vaccination of HIV-1-Infected Patients on ART

(2010) Bernard J. C. Macatangay et al.   PLoS One

PD-1 and CTLA-4 Inhibitory Cosignaling Pathways in HIV Infection and the Potential for Therapeutic Intervention

(2009) Daniel E. Kaufmann et al.   JOURNAL OF IMMUNOLOGY

Delivery systems: a vaccine strategy for overcoming mucosal tolerance?

(2008) Jamie FS Mann et al.   Expert Review of Vaccines

Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses

(2008) Andreas Bråve et al.   VACCINE